AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33907075 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive Therapy (ECT)
Number of subjects: 1089
Study 33907075 — intervention group
Group type: COMPARATOR
Intervention: Non-Electroconvulsive Therapy (non-ECT)
Number of subjects: 1089
Study 33907075 — intervention group
Group type: COMPARATOR
Intervention: Background cohort (randomly selected individuals)
Number of subjects: 1089
Study 33907075 — intervention group
Group type: COMPARATOR
Intervention: Non-ECT cohort
Number of subjects: 1089
Study 33907075 — intervention group
Group type: COMPARATOR
Intervention: Background cohort
Number of subjects: 1089
Study 34475137 — intervention group
Group type: EXPERIMENTAL
Intervention: ComHIP (Community-based Hypertension Improvement Project)
Number of subjects: 0
Study 34475137 — intervention group
Group type: COMPARATOR
Intervention: Standard hypertension care
Number of subjects: 0
Study 32266952 — intervention group
Group type: EXPERIMENTAL
Intervention: Current Fetal Surgery Center (CFSC)
Number of subjects: 198
Study 32266952 — intervention group
Group type: COMPARATOR
Intervention: Previous Fetal Surgery Center (PFSC)
Number of subjects: 198
Study 32266952 — intervention group
Group type: EXPERIMENTAL
Intervention: CFSC
Number of subjects: 198
Study 32266952 — intervention group
Group type: COMPARATOR
Intervention: PFSC
Number of subjects: 198
Study 32266952 — intervention group
Group type: COMPARATOR
Intervention: MOMS
Number of subjects: 198
Study 36469320 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium butyrate, 20 mg/kg body weight per day for 6 months
Number of subjects: 54
Study 36469320 — intervention group
Group type: COMPARATOR
Intervention: Standard care for pediatric obesity (placebo)
Number of subjects: 54
Study 36469320 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium butyrate
Number of subjects: 54
Study 33453383 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenite-loaded chitosan nanoparticles (SeChNPs) 0.5 g/kg diet
Number of subjects: 400
Study 33453383 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenite-loaded chitosan nanoparticles (SeChNPs) 1 g/kg diet
Number of subjects: 400
Study 33453383 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenite-loaded chitosan nanoparticles (SeChNPs) 2 g/kg diet
Number of subjects: 400
Study 33453383 — intervention group
Group type: COMPARATOR
Intervention: Control group (basal diet with inorganic selenium)
Number of subjects: 400
Study 33411186 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA) group
Number of subjects: 91
Study 33411186 — intervention group
Group type: COMPARATOR
Intervention: Primary snoring (PS) group
Number of subjects: 91
Study 33856434 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication group (topical ocular hypotensive medication)
Number of subjects: 1636
Study 33856434 — intervention group
Group type: COMPARATOR
Intervention: Observation group (close observation)
Number of subjects: 1636
Study 33856434 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 1636
Study 33856434 — intervention group
Group type: EXPERIMENTAL
Intervention: Black/African American participants
Number of subjects: 1636
Study 33856434 — intervention group
Group type: EXPERIMENTAL
Intervention: Other races
Number of subjects: 1636
Study 33856434 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk tertile
Number of subjects: 1636
Study 33856434 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-risk tertile
Number of subjects: 1636
Study 33856434 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk tertile
Number of subjects: 1636
Study 36687222 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematoma-directed ultrasound-guided lumpectomy (HDUGL)
Number of subjects: 25
Study 36687222 — intervention group
Group type: COMPARATOR
Intervention: Wire-guided lumpectomy (WGL)
Number of subjects: 25
Study 32594884 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose plus paraffin
Number of subjects: 363
Study 32594884 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol
Number of subjects: 363
Study 32779952 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 1.5 g twice daily
Number of subjects: 0
Study 32779952 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) 25 mg weekly
Number of subjects: 0
Study 35612905 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic VR (EaseVRx)
Number of subjects: 188
Study 35612905 — intervention group
Group type: COMPARATOR
Intervention: Sham VR
Number of subjects: 188
Study 32921136 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasoseptal flap (NSF) elevation
Number of subjects: 31
Study 32921136 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasoseptal flap (NSF) elevation on the side of dominant olfaction
Number of subjects: 31
Study 32921136 — intervention group
Group type: COMPARATOR
Intervention: Control group (EEA without NSF)
Number of subjects: 31
Study 32921136 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in rhinologic QOL as determined by Sinonasal Outcomes Test 22
Number of subjects: 31
Study 32790845 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO (300 U/kg once daily from days 14 to 28 after UCBT)
Number of subjects: 120
Study 32790845 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 35658857 — intervention group
Group type: EXPERIMENTAL
Intervention: REACT intervention (physical activity and behaviour maintenance)
Number of subjects: 25
Study 33227408 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative chemotherapy (CT)
Number of subjects: 788
Study 33227408 — intervention group
Group type: COMPARATOR
Intervention: Post-operative chemoradiotherapy (CRT)
Number of subjects: 788
Study 34256716 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban adolescents
Number of subjects: 2031
Study 34256716 — intervention group
Group type: COMPARATOR
Intervention: Rural adolescents
Number of subjects: 2031
Study 34256716 — intervention group
Group type: EXPERIMENTAL
Intervention: Both urban and rural adolescents
Number of subjects: 2031
Study 32519928 — intervention group
Group type: EXPERIMENTAL
Intervention: Patisiran
Number of subjects: 252
Study 33979325 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive chemotherapy (PCT) for soil-transmitted helminths (STH)
Number of subjects: 6102
Study 33979325 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors associated with STH infection
Number of subjects: 6102
Study 33979325 — intervention group
Group type: COMPARATOR
Intervention: Access to sanitation, handwashing facilities, or water facilities
Number of subjects: 6102
Study 32660575 — intervention group
Group type: EXPERIMENTAL
Intervention: High SOC group (SOC10 > 45)
Number of subjects: 97
Study 32660575 — intervention group
Group type: EXPERIMENTAL
Intervention: Working hours
Number of subjects: 97
Study 32660575 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC10
Number of subjects: 97
Study 32660575 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall burnout
Number of subjects: 97
Study 32660575 — intervention group
Group type: EXPERIMENTAL
Intervention: Burnout in the third month
Number of subjects: 97
Study 32660575 — intervention group
Group type: EXPERIMENTAL
Intervention: Burnout in the fifteenth month
Number of subjects: 97
Study 32660575 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 97
Study 34878438 — intervention group
Group type: EXPERIMENTAL
Intervention: TFV IVR
Number of subjects: 22
Study 34878438 — intervention group
Group type: COMPARATOR
Intervention: TDF/FTC oral tablets
Number of subjects: 22
Study 34034612 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine 1.5 mg/d
Number of subjects: 393
Study 34034612 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine 3 mg/d
Number of subjects: 393
Study 34034612 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 393
Study 35679127 — intervention group
Group type: EXPERIMENTAL
Intervention: Milled bar overdentures (MO)
Number of subjects: 16
Study 35679127 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed restoration (FR)
Number of subjects: 16
Study 35679127 — intervention group
Group type: COMPARATOR
Intervention: Conventional dentures (CD)
Number of subjects: 16
Study 32745532 — intervention group
Group type: EXPERIMENTAL
Intervention: Double high-level disinfection (DHLD)
Number of subjects: 878
Study 32745532 — intervention group
Group type: COMPARATOR
Intervention: Liquid chemical sterilization (LCS)
Number of subjects: 878
Study 32761668 — intervention group
Group type: COMPARATOR
Intervention: CTRL
Number of subjects: 200
Study 32761668 — intervention group
Group type: EXPERIMENTAL
Intervention: PE
Number of subjects: 200
Study 32761668 — intervention group
Group type: EXPERIMENTAL
Intervention: PTB
Number of subjects: 200
Study 32761668 — intervention group
Group type: EXPERIMENTAL
Intervention: IUGR
Number of subjects: 200
Study 35715764 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated oxygen control
Number of subjects: 58
Study 35715764 — intervention group
Group type: COMPARATOR
Intervention: Manual oxygen control
Number of subjects: 58
Study 36048465 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature-Controlled Radiofrequency (TCRF) device treatment of the nasal valve
Number of subjects: 108
Study 36048465 — intervention group
Group type: COMPARATOR
Intervention: Sham control procedure (no RF energy)
Number of subjects: 108
Study 32893136 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional medication assessment
Number of subjects: 512
Study 32893136 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 512
Study 33340284 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-month refill intervention ACs
Number of subjects: 2150
Study 33340284 — intervention group
Group type: COMPARATOR
Intervention: Standard of care ACs
Number of subjects: 2150
Study 35623551 — intervention group
Group type: EXPERIMENTAL
Intervention: Splenic vein embolization (SVE)
Number of subjects: 8
Study 33166026 — intervention group
Group type: EXPERIMENTAL
Intervention: Wi-Fi exposure (2.45 GHz)
Number of subjects: 30
Study 33166026 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 30
Study 34246324 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeling Safe Programme
Number of subjects: 130
Study 34246324 — intervention group
Group type: COMPARATOR
Intervention: Befriending
Number of subjects: 130
Study 33226875 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Coronary Angiography
Number of subjects: 0
Study 33226875 — intervention group
Group type: COMPARATOR
Intervention: No Early Coronary Angiography
Number of subjects: 0
Study 35903872 — intervention group
Group type: EXPERIMENTAL
Intervention: NEET youth
Number of subjects: 355
Study 35903872 — intervention group
Group type: COMPARATOR
Intervention: Non-NEET youth
Number of subjects: 355
Study 34259467 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper T380A IUD
Number of subjects: 655
Study 34259467 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel 52‐mg intrauterine system
Number of subjects: 655
Study 34259467 — intervention group
Group type: EXPERIMENTAL
Intervention: Single unprotected intercourse episodes
Number of subjects: 655
Study 34259467 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprotected intercourse 5 or fewer days before IUD placement
Number of subjects: 655
Study 33314883 — intervention group
Group type: EXPERIMENTAL
Intervention: Retro-walking (RW) with structured resistance training (SRT) 3 times a week for 12 weeks
Number of subjects: 34
Study 34671041 — intervention group
Group type: EXPERIMENTAL
Intervention: Stylet angulation at the holding position
Number of subjects: 60
Study 34671041 — intervention group
Group type: COMPARATOR
Intervention: No stylet angulation at the holding position (non-angulation group)
Number of subjects: 60
Study 34171293 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT + R training (8 sessions, 1/week, 30 minutes each session, consisting of ten 3-minute bouts of high-intensity treadmill walking and resistance training)
Number of subjects: 90
Study 34171293 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (conventional medical treatment)
Number of subjects: 90
Study 33853014 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive and emotional remediation training for depression (CERT‐D)
Number of subjects: 112
Study 33853014 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 112
Study 35042554 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma-Lyte 148 (Plasmalyte)
Number of subjects: 800
Study 35042554 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 800
Study 32014843 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based menu planning intervention
Number of subjects: 54
Study 32014843 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 54
Study 36326113 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group reading about a celebration with meatless dishes
Number of subjects: 246
Study 36326113 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group emphasizing that the host became a vegetarian after years of religious fasting
Number of subjects: 246
Study 36326113 — intervention group
Group type: COMPARATOR
Intervention: Control group reading about a celebration with meat-based meals
Number of subjects: 246
Study 33500146 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced crystalloids
Number of subjects: 2029
Study 33500146 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 2029
Study 32104921 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.45 GHz Wi-Fi exposure with a total antenna input power of 220 mW; specific absorption rate (SAR) in cortical brain regions approximately 1-2 mW/kg.
Number of subjects: 0
Study 32104921 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure (control group); details of the sham exposure not specified.
Number of subjects: 0
Study 34087746 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive group
Number of subjects: 41
Study 34087746 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 34087746 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 41
Study 32216829 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP 710
Number of subjects: 558
Study 32216829 — intervention group
Group type: COMPARATOR
Intervention: Infliximab reference product (RP)
Number of subjects: 558
Study 32216829 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP 710 and RP
Number of subjects: 558
Study 34528495 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises for 25 to 30 minutes every day for 4 weeks
Number of subjects: 90
Study 34528495 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 90
Study 35851283 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based child care (HBCC) delivered through village health workers (VHWs)
Number of subjects: 7656
Study 35851283 — intervention group
Group type: COMPARATOR
Intervention: Control areas (CA)
Number of subjects: 7656
Study 32854566 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (USG) for catheter insertion at a distance of 4 to 10 cm from wrist joint
Number of subjects: 103
Study 32854566 — intervention group
Group type: COMPARATOR
Intervention: Blind insertion of radial artery catheter
Number of subjects: 103
Study 32959557 — intervention group
Group type: EXPERIMENTAL
Intervention: Penetrating needling at Cuanzhu (BL2) and Yuyao (EX-HN4) combined with perpendicular needling at Shenmai (BL62) for 10 days, 2 courses.
Number of subjects: 64
Study 32959557 — intervention group
Group type: COMPARATOR
Intervention: Prednisone acetate (30 mg/d for 5 days, then reduced to 10 mg/d for 1 week) and muscular injection with vitamin B12 (0.5 mg) and B1 (0.1 mg) daily, followed by oral vitamin B1 (10 mg, three times a day for 10 days).
Number of subjects: 64
Study 33509729 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic RYGB (R-RYGB)
Number of subjects: 21736
Study 33509729 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic RYGB (R-RYGB) in super-obese patients
Number of subjects: 21736
Study 32356074 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP therapy
Number of subjects: 22
Study 32356074 — intervention group
Group type: COMPARATOR
Intervention: Sham CPAP therapy
Number of subjects: 22
Study 35182035 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insulin capsule (ORMD‐0801) 8 mg
Number of subjects: 70
Study 35182035 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insulin capsule (ORMD‐0801) 48 mg
Number of subjects: 70
Study 35182035 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insulin capsule (ORMD‐0801) 8 mg (stage 2)
Number of subjects: 70
Study 35182035 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insulin capsule (ORMD‐0801) 32 mg (stage 2)
Number of subjects: 70
Study 35182035 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insulin capsule (ORMD‐0801) 48 mg (stage 2)
Number of subjects: 70
Study 35182035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 35182035 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insulin capsule (ORMD‐0801) 8-48 mg (both stages)
Number of subjects: 70
Study 34481972 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet with additional extra virgin olive oil (40 mL daily) and pistachios (25 to 30 g daily)
Number of subjects: 560
Study 34481972 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet (control group)
Number of subjects: 560
Study 33386906 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular coils (EC)
Number of subjects: 46
Study 33386906 — intervention group
Group type: COMPARATOR
Intervention: Vascular plugs (VP)
Number of subjects: 46
Study 33386906 — intervention group
Group type: EXPERIMENTAL
Intervention: Both EC and VP
Number of subjects: 46
Study 35896299 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive preimplantation genetic testing (ni-PGT)
Number of subjects: 1148
Study 35896299 — intervention group
Group type: COMPARATOR
Intervention: Conventional morphology
Number of subjects: 1148
Study 32149586 — intervention group
Group type: EXPERIMENTAL
Intervention: Error Management Training (EMT)
Number of subjects: 42
Study 32149586 — intervention group
Group type: COMPARATOR
Intervention: Error Avoidance Training (EAT)
Number of subjects: 42
Study 36370336 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 0.3%
Number of subjects: 0
Study 36370336 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 0.15%
Number of subjects: 0
Study 36370336 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast (both dosages)
Number of subjects: 0
Study 36370336 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 34732484 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made insoles (n=70)
Number of subjects: 116
Study 34732484 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=46)
Number of subjects: 116
Study 32535403 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac autonomic balance (CAB)
Number of subjects: 96
Study 32535403 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no stressor)
Number of subjects: 96
Study 36063555 — intervention group
Group type: EXPERIMENTAL
Intervention: Awake prone positioning
Number of subjects: 0
Study 36063555 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 33098997 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of standard doses of FOLFOX/CAPOX
Number of subjects: 3759
Study 33098997 — intervention group
Group type: COMPARATOR
Intervention: 6 months of standard doses of FOLFOX/CAPOX
Number of subjects: 3759
Study 35325257 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg oral dose)
Number of subjects: 47
Study 35325257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 36123066 — intervention group
Group type: EXPERIMENTAL
Intervention: Email-based nudges based on peer behaviour
Number of subjects: 19
Study 36123066 — intervention group
Group type: EXPERIMENTAL
Intervention: Email-based nudges based on best practice guidelines
Number of subjects: 19
Study 36123066 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nudges)
Number of subjects: 19
Study 33913765 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum DMPA administration
Number of subjects: 170
Study 33913765 — intervention group
Group type: COMPARATOR
Intervention: No DMPA administration (Control)
Number of subjects: 170
Study 35869741 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM)
Number of subjects: 1082
Study 35869741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1082
Study 32885541 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐AR cream containing GSH‐C4 (0.1%), beta‐Glycyrrhetic (0.5%), and azelaic acids (10%) applied daily for 8 weeks
Number of subjects: 30
Study 32885541 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐AR cream
Number of subjects: 30
Study 36307922 — intervention group
Group type: EXPERIMENTAL
Intervention: CETP inhibitor TA-8995 (obicetrapib)
Number of subjects: 242
Study 36307922 — intervention group
Group type: EXPERIMENTAL
Intervention: Friedewald equation
Number of subjects: 242
Study 36307922 — intervention group
Group type: EXPERIMENTAL
Intervention: Martin/Hopkins equation
Number of subjects: 242
Study 36307922 — intervention group
Group type: EXPERIMENTAL
Intervention: Sampson equation
Number of subjects: 242
Study 33155876 — intervention group
Group type: EXPERIMENTAL
Intervention: DNC
Number of subjects: 200
Study 33155876 — intervention group
Group type: EXPERIMENTAL
Intervention: DNC-R
Number of subjects: 200
Study 33155876 — intervention group
Group type: COMPARATOR
Intervention: HTK
Number of subjects: 200
Study 33155876 — intervention group
Group type: COMPARATOR
Intervention: HTK-R
Number of subjects: 200
Study 32948577 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine or chloroquine
Number of subjects: 200000
Study 32948577 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 200000
Study 32948577 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 200000
Study 32948577 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir
Number of subjects: 200000
Study 32948577 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem cell treatments
Number of subjects: 200000